Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
human growth hormone
Pharma
Crinetics breaks commercial barrier with Palsonify FDA nod
After nearly two decades in the endocrine scene, Crinetics is making its market debut with approval for a new oral drug in a rare hormone disorder.
Fraiser Kansteiner
Sep 25, 2025 5:30pm
Novo heads to regulators after Sogroya posts positive results
May 13, 2025 9:50am
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
Pfizer, Opko gain FDA nod for weekly growth hormone drug Ngenla
Jun 28, 2023 10:42am
Lumos' oral growth hormone drug falls short of Novo injectable
Nov 15, 2022 9:00am
